Antares Pharma Inc (ATRS.OQ)
ATRS.OQ on NASDAQ Stock Exchange Capital Market
3.34USD
19 Oct 2018
3.34USD
19 Oct 2018
Change (% chg)
$-0.09 (-2.62%)
$-0.09 (-2.62%)
Prev Close
$3.43
$3.43
Open
$3.43
$3.43
Day's High
$3.49
$3.49
Day's Low
$3.34
$3.34
Volume
165,655
165,655
Avg. Vol
239,415
239,415
52-wk High
$3.93
$3.93
52-wk Low
$1.59
$1.59
Revenue & Earnings Per Share
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 32.09 | 33.64 | |
| P/E High - Last 5 Yrs. | -- | 40.38 | 45.19 | |
| P/E Low - Last 5 Yrs. | -- | 19.64 | 23.75 | |
| Beta | 0.28 | 0.79 | 0.88 | |
| Price to Sales (TTM) | 305.28 | 6.72 | 5.83 | |
| Price to Book (MRQ) | -- | 4.96 | 4.89 | |
| Price to Tangible Book (MRQ) | -- | 16.70 | 6.51 | |
| Price to Cash Flow (TTM) | -- | 21.72 | 22.92 | |
| % Owned Institutions | -- | 4.48 | 2.14 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.05 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 1.25 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 16.31 | 5.40 | |
| Payout Ratio(TTM) | -- | 30.84 | 43.85 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -64.35 | 8.71 | 8.10 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -42.76 | 2.04 | 5.80 | |
| Sales - 5 Yr. Growth Rate | -5.00 | 8.60 | 9.87 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -54.02 | 59.38 | 23.38 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -28.03 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 19.77 | 10.92 | |
| Capital Spending - 5 Yr. Growth Rate | 36.90 | 7.87 | 14.87 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 0.14 | 2.44 | 2.25 |
| Current Ratio (MRQ) | 0.22 | 3.17 | 3.05 |
| LT Debt to Equity (MRQ) | -- | 29.22 | 12.76 |
| Total Debt to Equity (MRQ) | -- | 36.11 | 17.18 |
| Interest Coverage (TTM) | -149.72 | 15.34 | 37.50 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 17.36 | 59.08 | 54.87 | |
| Gross Margin - 5 Yr. Avg. | 50.95 | 58.56 | 52.39 | |
| EBITD Margin (TTM) | -153.74 | -- | -- | |
| EBITD - 5 Yr. Avg | -110.22 | 23.05 | 11.01 | |
| Operating Margin (TTM) | -244.46 | 17.84 | 4.07 | |
| Operating Margin - 5 Yr. Avg. | -131.86 | 15.92 | 6.34 | |
| Pre-Tax Margin (TTM) | -244.96 | 17.60 | 5.12 | |
| Pre-Tax Margin - 5 Yr. Avg. | -125.55 | 16.20 | 6.78 | |
| Net Profit Margin (TTM) | -244.96 | 13.47 | 1.39 | |
| Net Profit Margin - 5 Yr. Avg. | -125.55 | 11.32 | 3.03 | |
| Effective Tax Rate (TTM) | -- | 23.14 | 23.24 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 28.79 | 24.16 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 53,082 | 28,641,671 | 808,218,600 | |
| Net Income/Employee (TTM) | -130,029 | 3,214,643 | 95,058,584 | |
| Receivable Turnover (TTM) | 10.46 | 5.06 | 5.78 | |
| Inventory Turnover (TTM) | 3.58 | 3.19 | 3.63 | |
| Asset Turnover (TTM) | 0.80 | 0.79 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -195.99 | 10.53 | 10.90 | |
| Return on Assets - 5 Yr. Avg. | -60.29 | 9.03 | 12.01 | |
| Return on Investment (TTM) | -- | 13.81 | 14.27 | |
| Return on Investment - 5 Yr. Avg. | -76.85 | 11.69 | 15.60 | |
| Return on Equity (TTM) | -- | 16.56 | 15.99 | |
| Return on Equity - 5 Yr. Avg. | -79.39 | 13.98 | 16.87 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -42.76 | -18.76 | -5.00 |
| EPS (TTM) % | -28.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Antares Pharma Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 23.61 | 12.66 | 90 | 47 |
| 13 Week | 7.37 | -0.08 | 65 | 69 |
| 26 Week | 2.42 | 16.39 | 43 | 61 |
| 52 Week | 38.61 | 55.81 | 75 | 37 |
| YTD | 2.36 | -4.98 | 35 | 35 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.